InsiderTrades

Form 4 for STRO SUTRO BIOPHARMA, INC.

Accepted 2026-09-22 16:09:25 ET · period of report 2026-09-18 · accession 0001992979-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-09-22 16:09 2026-09-18 STRO Gerber Hans-Peter CSO M - OptEx $0.00 +3,750 13.7K +38% $0
D 2026-09-22 16:09 2026-09-18 STRO Gerber Hans-Peter CSO F - Tax $15.34 -1,345 12.4K -10% -$20.6K
D 2026-09-22 16:09 2026-09-18 STRO Gerber Hans-Peter CSO M - OptEx $0.00 -3,750 3,750 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-09-18 M A 3,750 $0.00 13,712 D — — (F1) The reported total includes 444 shares of Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its Employee Stock Purchase Plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c).
2 Common Common Stock 2026-09-18 F D 1,345 $15.34 12,367 D — — (F2) Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
3 Derivative Restricted Stock Units (RSUs) 2026-09-18 M D 3,750 $0.00 3,750 D — · — to 2027-09-18 3,750 Common Stock (F3) Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F4) The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on September 18, 2024, subject to the reporting person's continued service through each vesting date.